Sanders Morris Harris LLC Lantern Pharma Inc. Transaction History

Sanders Morris Harris LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 07, 2022	SELL	$4.59 - $6.5 $459 - $650	-100 Reduced 0.03%	365,930 $1.72 Million
Q2 2022 Jul 11, 2022	SELL	$4.82 - $7.45 $87,714 - $135,575	-18,198 Reduced 4.74%	366,030 $2.06 Million
Q1 2022 Apr 11, 2022	BUY	$5.6 - $8.22 $267,696 - $392,940	47,803 Added 14.21%	384,228 $2.75 Million
Q4 2021 Feb 02, 2022	BUY	$7.11 - $11.04 $2.39 Million - $3.71 Million	336,425 New	336,425 $2.57 Million

1.28M

39.8K

6.1K

Ticker LTRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,830,900
Market Cap $54.2M
Description
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...

Get notified when there are updates to the investment portfolio of Sanders Morris Harris LLC, based on Form 13F filings with the SEC.

Stay updated on Sanders Morris Harris LLC with notifications on news.